| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8823817 | Journal of Vascular and Interventional Radiology | 2018 | 10 Pages |
Abstract
Use of TARE in patients with HCC has been increasing. Several factors are significantly associated with a less favorable outcome after TARE, including male sex, large tumors, and extrahepatic disease. These data can be used for designing future radioembolization trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Samer MD, Patrick MD, Christof MD, Alexis P. MD, PhD, Patrick R. MD, Allan MD,